Literature DB >> 11462014

High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus.

M Trottier1, P Kallio, W Wang, H L Lipton.   

Abstract

The low-neurovirulence Theiler's murine encephalomyelitis viruses (TMEV), such as BeAn virus, cause a persistent infection of the central nervous system (CNS) in susceptible mouse strains that results in inflammatory demyelination. The ability of TMEV to persist in the mouse CNS has traditionally been demonstrated by recovering infectious virus from the spinal cord. Results of infectivity assays led to the notion that TMEV persists at low levels. In the present study, we analyzed the copy number of TMEV genomes, plus- to minus-strand ratios, and full-length species in the spinal cords of infected mice and infected tissue culture cells by using Northern hybridization. Considering the low levels of infectious virus in the spinal cord, a surprisingly large number of viral genomes (mean of 3.0 x 10(9)) was detected in persistently infected mice. In the transition from the acute (approximately postinfection [p.i.] day 7) to the persistent (beginning on p.i. day 28) phase of infection, viral RNA copy numbers steadily increased, indicating that TMEV persistence involves active viral RNA replication. Further, BeAn viral genomes were full-length in size; i.e., no subgenomic species were detected and the ratio of BeAn virus plus- to minus-strand RNA indicated that viral RNA replication is unperturbed in the mouse spinal cord. Analysis of cultured macrophages and oligodendrocytes suggests that either of these cell types can potentially synthesize high numbers of viral RNA copies if infected in the spinal cord and therefore account for the heavy viral load. A scheme is presented for the direct isolation of both cell types directly from infected spinal cords for further viral analyses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11462014      PMCID: PMC114977          DOI: 10.1128/JVI.75.16.7420-7428.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Directed establishment of rat brain cell lines with the phenotypic characteristics of type 1 astrocytes.

Authors:  E H Radany; M Brenner; F Besnard; V Bigornia; J M Bishop; C F Deschepper
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

2.  Infection of macrophages by Theiler's murine encephalomyelitis virus is highly dependent on their activation or differentiation state.

Authors:  C Shaw-Jackson; T Michiels
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  An early, abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing viral persistence.

Authors:  S Dethlefs; M Brahic; E L Larsson-Sciard
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Improved method for detecting poliovirus negative strands used to demonstrate specificity of positive-strand encapsidation and the ratio of positive to negative strands in infected cells.

Authors:  J E Novak; K Kirkegaard
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  The rhinovirus type 14 genome contains an internally located RNA structure that is required for viral replication.

Authors:  K L McKnight; S M Lemon
Journal:  RNA       Date:  1998-12       Impact factor: 4.942

6.  The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system.

Authors:  M K Njenga; K Asakura; S F Hunter; P Wettstein; L R Pease; M Rodriguez
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity.

Authors:  X Lin; L R Pease; P D Murray; M Rodriguez
Journal:  J Immunol       Date:  1998-06-01       Impact factor: 5.422

8.  Differentiation of M1 myeloid precursor cells into macrophages results in binding and infection by Theiler's murine encephalomyelitis virus and apoptosis.

Authors:  M L Jelachich; C Bramlage; H L Lipton
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques.

Authors:  P Ten Haaft; B Verstrepen; K Uberla; B Rosenwirth; J Heeney
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Characterization of and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler's murine encephalomyelitis virus.

Authors:  J G Pope; C L Vanderlugt; S M Rahbe; H L Lipton; S D Miller
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

View more
  24 in total

1.  Bone marrow chimeras reveal non-H-2 hematopoietic control of susceptibility to Theiler's virus persistent infection.

Authors:  Stéphanie Aubagnac; Michel Brahic; Jean-François Bureau
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Theiler's virus infection of primary cultures of bone marrow-derived monocytes/macrophages.

Authors:  Cécile Martinat; Ignacio Mena; Michel Brahic
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  The antiapoptotic protein Mcl-1 controls the type of cell death in Theiler's virus-infected BHK-21 cells.

Authors:  Sevim Yildiz Arslan; Kyung-No Son; Howard L Lipton
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

4.  Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus.

Authors:  Laurie J Zoecklein; Kevin D Pavelko; Jeff Gamez; Louisa Papke; Dorian B McGavern; Daren R Ure; M Kariuki Njenga; Aaron J Johnson; Shunya Nakane; Moses Rodriguez
Journal:  Brain Pathol       Date:  2003-07       Impact factor: 6.508

5.  Treatment of Theiler's virus-induced demyelinating disease with teriflunomide.

Authors:  Francesca Gilli; Libin Li; Darlene B Royce; Krista D DiSano; Andrew R Pachner
Journal:  J Neurovirol       Date:  2017-09-14       Impact factor: 2.643

Review 6.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

7.  Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus.

Authors:  Paul T Massa; Stacie L Ropka; Sucharita Saha; Karen L Fecenko; Kathryn L Beuler
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Theiler's murine encephalomyelitis virus L* amino acid position 93 is important for virus persistence and virus-induced demyelination.

Authors:  Spyridon Stavrou; Gleb Baida; Ekaterina Viktorova; Ghanashyam Ghadge; Vadim I Agol; Raymond P Roos
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

9.  Human HLA-DR transgenes protect mice from fatal virus-induced encephalomyelitis and chronic demyelination.

Authors:  Moses Rodriguez; Laurie Zoecklein; Jason G Kerkvliet; Kevin D Pavelko; Louisa Papke; Charles L Howe; Larry R Pease; Chella David
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

10.  Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212.

Authors:  J Ludovic Croxford; Stephen D Miller
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.